{
  "term": "Nizatidine",
  "role": "concept",
  "parent_concepts": [
    "Medicine"
  ],
  "layer": 5,
  "domain": "PhysicalWorld",
  "definition": "Nizatidine is a histamine\nH2 receptor antagonist that inhibits stomach acid production, and is\ncommonly used in the treatment of peptic ulcer disease and\ngastroesophageal reflux disease. It was patented in 1980 and\napproved for medical use in 1988. It was developed by Eli Lilly.\nBrand names include Tazac and Axid. [from Wikipedia]",
  "definition_source": "SUMO",
  "aliases": [
    "nizatidine"
  ],
  "wordnet": {
    "synsets": [
      "nizatidine.n.01"
    ],
    "canonical_synset": "nizatidine.n.01",
    "lemmas": [
      "nizatidine"
    ],
    "pos": "noun"
  },
  "relationships": {
    "related": [],
    "antonyms": [],
    "has_part": [
      "Axid",
      "Tazac"
    ],
    "part_of": []
  },
  "safety_tags": {
    "risk_level": "low",
    "impacts": [],
    "treaty_relevant": false,
    "harness_relevant": false
  },
  "training_hints": {
    "positive_examples": [],
    "negative_examples": [],
    "disambiguation": "",
    "seed_terms": [
      "nizatidine"
    ]
  },
  "children": [
    "Axid",
    "Tazac"
  ],
  "is_category_lens": true,
  "child_count": 2
}